Skip to main content
Log in

A Comparative Dissolution Kinetics Test for Omeprazole-Containing Medicines, Reproducing Secretory and Motor-Evacuatory Impairments the Stomach of Patients with Acid-Dependent Diseases

  • STRUCTURE OF CHEMICAL COMPOUNDS, METHODS OF ANALYSIS AND PROCESS CONTROL
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A comparative dissolution kinetics test was used to study the release (dissolution kinetics) of an original and 10 generic formulations of omeprazole from different manufacturers in a medium simulating the moderately acidic conditions in the stomach typical of the state of medication-induced suppression of acidity; tests were also performed in a model of pathological duodenogastric reflux. HPLC was used to measure omeprazole concentrations in aliquots collected at 4, 10, 15, 20, 30, 45, and 60 min in solution with pH 7.0 ± 0.05 after 2 h of exposure at pH 1.2 ± 0.05 or 4.0 ± 0.05. The duration of action of pathological duodenogastric reflux on the therapeutic formulations of omeprazole was 4 min. Not all the study formulations could be completely recognized as equivalents to the original formulation in the in vitro test conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. B. K. Romanov, N. D. Bunyatyan, Yu. V. Olefir, et al., Vedom. Nauch. Tsentra Ékspert. Sredstv Med. Primenen., No. 2, 3 – 8 (2015).

  2. D. P. Romodanovskii, D. V. Goryachev, Yu. V. Olefir, and N. D. Bunyatyan, Khim.-farm. Zh., 50(12), 42 – 45 (2016); Pharm. Chem. J., 50(12), 814 – 816 (2016).

  3. A. V. Sokolov, Yu. B. Belousov, S. K. Zyryanov, et al., Farmakokin. Farmakodin., No. 1, 43 – 49 (2012).

  4. D. Yu. Grebenkin, Ya. M. Stanishevskii, and I. E. Shokhin, Éffekt. Bezopasn. Lek. Sredstv, 14(1), 166 – 171 (2016).

    Google Scholar 

  5. https: //www.accessdata.fda.gov/scripts/cder/dissolution/dsp Search Results.cfm (accessed on April 26, 2017).

  6. A. El-Sayed, N. A. Boraie, F. A. Ismail, et al., Eastern Mediter. Nealth J., 13(6), 1427 – 1434 (2007).

    CAS  Google Scholar 

  7. V. N. Satsukevich, D. V. Satsukevich, Risk Factors for Acute Complications of Gastroduodenal Ulcers [in Russian], Libereya, Moscow (1999).

    Google Scholar 

  8. K. H. Fuchs, T. R. DeMeester, R. A. Hinder, et al., Ann. Surg, 213(1), 13 – 20 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. N. J. Bell, Digestion, 51(1), 59 – 67 (1993).

    Article  Google Scholar 

  10. Guidelines for Expert Assessment of Drugs [in Russian], Grif i K, Moscow (2013), Vol. 1.

  11. I. E. Shokhin, G. V. Ramenskaya, G. V. Vasilenko, et al., Methodological Guidelines for Drug Developers and Manufacturers for Studies of the Comparative Dissolution Kinetics of Generic Formulations, Moscow (2010).

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 9, pp. 55 – 59, September, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vasilenko, G.F., Krasnykh, L.M., Serebrova, S.Y. et al. A Comparative Dissolution Kinetics Test for Omeprazole-Containing Medicines, Reproducing Secretory and Motor-Evacuatory Impairments the Stomach of Patients with Acid-Dependent Diseases. Pharm Chem J 51, 824–828 (2017). https://doi.org/10.1007/s11094-017-1700-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-017-1700-6

Keywords

Navigation